+852 2866 8995 General Enquiry: cs@medikonia.com | Support: support@medikonia.com

TargetMol Wortmannin

Synonyms: KY-12420, SL-2052. Catalog #: T6283

Product description Order information Resources Panel

All products from TargetMol are for Research Use Only. Not for Human or Veterinary or Therapeutic Use.

 

Biological Description

 

Description: Wortmannin is the first described PI3K inhibitor with IC50 of 3 nM, with little selectivity within the PI3K family. Also blocks autophagosome formation and potently inhibits DNA-PK/ATM with IC50 of 16 nM and 150 nM.

 

Targets&IC50: PI3K:3 nM, DNA-PK:16 nM, ATM:150 nM

 

In vitro: Mitomycin C, by inducing DNA interstrand crosslinks, physically blocks DNA replication, recombination, and RNA transcription. Mitomycin C potentiates TRAIL-induced apoptosis in HCT116 (p53-/-) colon cancer cells and sensitizes TRAIL-resistant colon cancer cells HT-29 to the cytokine by through JNK-independent upregulation of death receptors. [2] In different human cancer cell lines, such OVCAR-5 (ovary), HT-29 (colon), SK-N-MC (neuroblastoma), HEP-2 (liver), COLO-205 (colon), NIH-OVCAR-3 (ovary) and A-549 (lung) cells, Mitomycin C shows cytotoxic activity.

 

Chemical Properties

Molecular Weight: 428.437

Formula: C23H24O8

CAS No.: 19545-26-7

 

Storage & Solubility Information

Storage

Powder: -20°C for 3 years

In solvent: -80°C for 2 years

Solubility Information

Ethanol: 2.1 mg/mL (5 mM)), with gentle warming

DMSO: 21.4 mg/mL (50 mM)

( < 1 mg/ml refers to the product slightly soluble or insoluble )

 

Catalog #: T6283

Please email us at cs@medikonia.com for any enquiry. To place an order, please include the catalog number(s) of the product(s) in the email.